TERI LYNN: Open Payments
NPI 1225129976 · OREM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 41 payments from 15 companies in 2025. Trend: 2023 $786 · 2024 $498 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $262 |
| United Therapeutics Corporation | 4 | $111 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $84 |
| Merck Sharp & Dohme LLC | 4 | $69 |
| Abbott Laboratories | 1 | $34 |
| PFIZER INC. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
Products named: REPATHA, Tyvaso, LEQVIO, JARDIANCE, VERQUVO, MERLIN@HOME, ELIQUIS, PRALUENT.
Industry payments across UT — which companies pay providers there.
